gene

BACE1

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about BACE1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1397Connections
3Hypotheses
4Analyses
50Outgoing
50Incoming

Summary

Beta-site APP Cleaving Enzyme 1 (BACE1) is the rate-limiting enzyme in amyloid-beta production, performing the first cleavage of APP in the amyloidogenic pathway. BACE1 activity increases with age and in AD brains, driven by oxidative stress, inflammation, and impaired trafficking. BACE1 inhibitors were pursued as AD therapeutics but clinical trials (verubecestat, atabecestat, elenbecestat) failed due to cognitive worsening and synaptic toxicity, likely from inhibiting BACE1 cleavage of neuregulin-1 and other substrates critical for myelination and synaptic function. BACE1 knockout mice show seizures, hypomyelination, and behavioral deficits. Current approaches focus on partial BACE1 inhibition or substrate-selective strategies to reduce Abeta without off-target effects.

View on Wiki →

🧬 Gene Info
Gene SymbolBACE1
Full NameBeta-Site Amyloid Precursor Protein Cleaving Enzyme 1
Chromosome11q13.2
Protein TypeProtease
Target ClassProtease
FunctionBACE1 is a transmembrane aspartyl protease that catalyzes the ectodomain shedding of numerous type I membrane proteins
Mechanism of ActionSmall molecule inhibitor of aspartyl protease activity
DruggabilityMedium (0.48)
Clinical StagePhase III
PathwaysAmyloid, Apoptosis, Lipid Metabolism, Nf-Κb, Synaptic Plasticity
UniProt IDQ15118
NCBI Gene ID23626
Ensembl IDENSG00000186318
OMIM604252
GeneCardsBACE1
Human Protein AtlasBACE1
Associated DiseasesAD, ALS, AMI, Alzheimer, Alzheimer'S Disease
Known Drugs/CompoundsLiquiritigenin, Ginsenosides Rh4, BACE1 siRNA, DHA, aducanumab, lecanemab
InteractionsMTOR, AKT, CDK5, NLRP3, SMAD3, APP
SciDEX TargetView Target Profile (8 clinical trials)
SciDEX HypothesesPalmitoylation-Targeted BACE1 Trafficking Disrupto
KG Connections1388 knowledge graph edges
DatabasesGeneCardsHPASTRING
🧬 3D Structure: BACE1 — PDB 6EQM Click to expand

Experimental structure from RCSB PDB | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

BACE1 (Redirect)

redirect · 634 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

nimodipine-als

clinical_trial · 5778 words

Therapeutics

index · 5665 words

Alzheimer's Disease

disease · 5265 words

GSK-3β in Neurodegeneration

mechanism · 5020 words

Pathway Diagram

flowchart TD
    BACE1["BACE1<br/>beta-secretase"]
    APP["APP<br/>Amyloid Precursor<br/>Protein"]
    Abeta["Abeta peptides<br/>Amyloid Beta"]
    AD["Alzheimer's<br/>Disease"]
    ALS["ALS"]
    MS["Multiple<br/>Sclerosis"]
    
    TNF["TNF-alpha<br/>Pro-inflammatory<br/>Cytokine"]
    IL6["IL-6<br/>Pro-inflammatory<br/>Cytokine"]
    NFKB["NF-kappaB<br/>Transcription<br/>Factor"]
    JAK2_STAT1["JAK2-STAT1<br/>Signaling<br/>Pathway"]
    C1Q["C1Q<br/>Complement<br/>Protein"]
    
    AMPK["AMPK<br/>Energy Sensor"]
    Liquiritigenin["Liquiritigenin<br/>Natural Inhibitor"]
    Ginsenosides["Ginsenosides Rh4<br/>Natural Inhibitor"]
    BACE1_siRNA["BACE1 siRNA<br/>Therapeutic<br/>Inhibitor"]
    
    Neuroinflammation["Neuroinflammation"]
    Aging["Aging<br/>Process"]
    
    TNF --|"activates"|--> BACE1
    IL6 --|"activates"|--> BACE1
    NFKB --|"activates"|--> BACE1
    JAK2_STAT1 --|"regulates"|--> BACE1
    C1Q --|"regulates"|--> BACE1
    
    BACE1 --|"cleaves"|--> APP
    APP --|"produces"|--> Abeta
    BACE1 --|"promotes"|--> Abeta
    
    Abeta --|"drives"|--> AD
    BACE1 --|"associated_with"|--> AD
    BACE1 --|"therapeutic_target"|--> ALS
    BACE1 --|"therapeutic_target"|--> MS
    
    AMPK --|"inhibits"|--> BACE1
    Liquiritigenin --|"inhibits"|--> BACE1
    Ginsenosides --|"inhibits"|--> BACE1
    BACE1_siRNA --|"inhibits"|--> BACE1
    
    BACE1 --|"biomarker_for"|--> Neuroinflammation
    BACE1 --|"biomarker_for"|--> Aging
    
    style BACE1 fill:#006494
    style AMPK fill:#1b5e20
    style Liquiritigenin fill:#1b5e20
    style Ginsenosides fill:#1b5e20
    style BACE1_siRNA fill:#1b5e20
    style TNF fill:#ef5350
    style IL6 fill:#ef5350
    style Abeta fill:#ef5350
    style AD fill:#5d4400
    style ALS fill:#5d4400
    style MS fill:#5d4400
    style Neuroinflammation fill:#5d4400
    style NFKB fill:#4a1a6b
    style JAK2_STAT1 fill:#4a1a6b
    style C1Q fill:#4a1a6b

Outgoing (901)

TargetRelationTypeStr
ds-b3d65f2c2ca6provides_data_fordataset1.00
ds-83b31ef18d49provides_data_fordataset1.00
ds-6784494f1741provides_data_fordataset1.00
Alzheimertherapeutic_targetdisease0.95
AMYLOID-Βassociated_withentity0.95

Incoming (496)

SourceRelationTypeStr
AMYLOIDassociated_withgene1.00
ALZHEIMER'S DISEASEassociated_withdisease1.00
ds-b3d65f2c2ca6data_indataset1.00
ds-6784494f1741data_indataset1.00
ds-83b31ef18d49data_indataset1.00

Targeting Hypotheses (3)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
SGMS1-Driven Sphingomyelin Accumulation Impairs BACE1 Lysoso 0.542 neurodegeneration What molecular mechanisms link elevated
BACE1/NRG1 Axis Dysfunction Drives Excitatory/Inhibitory Imb 0.527 neurodegeneration What are the physiological functions of
Palmitoylation-Targeted BACE1 Trafficking Disruptors 0.407 neurodegeneration Lipid raft composition changes in synapt

Mentioning Analyses (4)

Scientific analyses that reference this entity

What are the physiological functions of BACE1 beyond APP processing that could c

neurodegeneration | 2026-04-15 | 1 hypotheses Top: 0.527

Digital biomarkers and AI-driven early detection of neurodegeneration

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.605

APOE4 structural biology and therapeutic targeting strategies

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.595

Lipid raft composition changes in synaptic neurodegeneration

neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.648

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease. [PMID:33803217] Chang CH, Lin CH, Lane HY Int J Mol Sci 2021 1
Blocking palmitoyl-transferase activity reduces BACE1 membrane localization and [PMID:23395894] Unknown Molecular Neurodegeneration 0
Amyloid-β fibrils accumulated in preeclamptic placentas suppress cytotrophoblast [PMID:41558820] Nishioka K, Ikezaki M, Iwahashi N, Araka Life Sci Alliance 2026 0
An anti-inflammatory neuroenhancer mitigates amyloid-β pathology to improve Alzh [PMID:41696149] Fang W, Zhao J, Li L, Wang Y, Xu ZP et a Mater Today Bio 2026 0
Anti-ASC antibodies alleviate Alzheimer's disease-type pathology in APP/PS1 mice [PMID:41707905] He L, Xiaopeng Z, Juan D, Yan L Neuroscience 2026 0
Intranasal administration of neural stem cell-derived extracellular vesicles pre [PMID:41923110] Natale F, Dellaria A, Nifo Sarrapochiell Alzheimer's research & therapy 2026 0
Salvianolic acid a inhibits neuroinflammation and ameliorates Alzheimer's diseas [PMID:41930874] Xiao S, Han Y, Yan J, Wu L, Lin H et al. Int Immunopharmacol 2026 0
Repurposing FDA-approved drugs as multi-target neuroprotective agents for Alzhei [PMID:41946775] Phemphunananchai K, Waiwut P, Phetcharab Scientific reports 2026 0
Nano-magnolol enhances the modulatory effects of magnolol on cognitive performan [PMID:41954680] Youssef B, Ibrahim EA, Moselhy SS, ElShe Discov Nano 2026 0
BACE-1 inhibitors as potential drug candidates for treatment of Alzheimer's dise [PMID:41966670] Kaur N, Gupta S, Bansal G, Bansal Y Mol Divers 2026 0
Alzheimer's disease basics: we all should know. [PMID:40639927] Das S Neurological research 2026 0
Demethyleneberberine attenuates combined cognitive and metabolic dysfunctions in [PMID:41482106] Kaur A, Singh S, Singh M, Silakari P, Ma Experimental neurology 2026 0
AMPK/SIRT1/PGC-1α Signaling Pathway: Molecular Mechanisms and Targeted Strategie [PMID:41268687] Chen J, Liu B, Yao X, Yang X, Sun J, Yi CNS neuroscience & therapeutic 2025 0
Proposed Therapeutic Strategy to Combat Alzheimer's Disease by Targeting Beta an [PMID:40491367] ["Kumar D", "Anand P", "Singh S"] Current Alzheimer research 2025 0
BACE1-dependent cleavage of GABAA receptor contributes to neural hyperexcitabili [PMID:40015276] Bi D, Bao H, Yang X, Wu Z, Yang X, Xu G, Neuron 2025 0
Unmasking BACE1 in aging and age-related diseases. [PMID:36509631] ["Bao H", "Shen Y"] Trends in molecular medicine 2023 0
BACE1: More than just a β-secretase. [PMID:35119166] ["Taylor H", "Przemylska L", "Clavane E" Obesity reviews : an official 2022 0
The β-Secretase BACE1 in Alzheimer's Disease. [PMID:32223911] ["Hampel H", "Vassar R", "De Strooper B" Biological psychiatry 2021 0
Early elevation of BACE1 in dementia. [PMID:34845111] Cervellati C, Valacchi G, Zuliani G Aging 2021 0
Identification of tell-tale patterns in the 3' non-coding region of hantaviruses [PMID:29559625] Sankar S, Borkakoti J, Ramamurthy M, Nan Emerging microbes & infections 2018 0